FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jeanette Pullen

Research Profile

Disorders

Living Beings

Infants

Chemicals & Drugs

Procedures

Concepts & Ideas

Treatment Outcome

Anatomy

Co-author Network

Publications

TOP 3
I-Ming Chen; Catherine E Cottrell; Meenakshi Devidas; Julie M Gastier-Foster; Richard C Harvey; Stephen P Hunger; Huining Kang; Mignon L Loh; Charles G Mullighan; Debbie Payne-Turner; D Jeanette Pullen; Gregory H Reaman; Shalini Reshmi; Sarah K Tasian; Walker Wharton; Michael J Borowitz; W Paul Bowman; Bruce M Camitta; Andrew J Carroll; William L Carroll; Naomi J Winick; Cheryl L Willman
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.
W Paul Bowman; Bruce M Camitta; Andrew J Carroll; William L Carroll; Meenakshi Devidas; Stephen P Hunger; Eric L Larsen; Stephen B Linda; D Jeanette Pullen; Jonathan Shuster; Cheryl L Willman; Naomi Winick; Laurie Blach; Michael J Borowitz
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.
Michael J Borowitz; Meenakshi Devidas; Stephen P Hunger; W Paul Bowman; Andrew J Carroll; William L Carroll; Stephen Linda; Paul L Martin; D Jeanette Pullen; David S Viswanatha; Cheryl L Willman; Naomi J Winick; Bruce M Camitta
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jeanette Pullen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: I-Ming Chen; Catherine E Cottrell; Meenakshi Devidas; Julie M Gastier-Foster; Richard C Harvey; Stephen P Hunger; Huining Kang; Mignon L Loh; Charles G Mullighan; Debbie Payne-Turner; D Jeanette Pullen; Gregory H Reaman; Shalini Reshmi; Sarah K Tasian; Walker Wharton; Michael J Borowitz; W Paul Bowman; Bruce M Camitta; Andrew J Carroll; William L Carroll; Naomi J Winick; Cheryl L Willman
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.
Blood 2012;119(15):3512-22.
2011: W Paul Bowman; Bruce M Camitta; Andrew J Carroll; William L Carroll; Meenakshi Devidas; Stephen P Hunger; Eric L Larsen; Stephen B Linda; D Jeanette Pullen; Jonathan Shuster; Cheryl L Willman; Naomi Winick; Laurie Blach; Michael J Borowitz
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.
Pediatric blood & cancer 2011;57(4):569-77.
2008: Michael J Borowitz; Meenakshi Devidas; Stephen P Hunger; W Paul Bowman; Andrew J Carroll; William L Carroll; Stephen Linda; Paul L Martin; D Jeanette Pullen; David S Viswanatha; Cheryl L Willman; Naomi J Winick; Bruce M Camitta
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.
Blood 2008;111(12):5477-85.
2007: Kirk R Schultz; D Jeanette Pullen; Harland Sather; Jonathan J Shuster; Meenakshi Devidas; Michael J Borowitz; Andrew J Carroll; Nyla A Heerema; Jeffrey E Rubnitz; Mignon L Loh; Elizabeth A Raetz; Naomi J Winick; Stephen P Hunger; William L Carroll; Paul S Gaynon; Bruce M Camitta
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
Blood 2007;109(3):926-35.
2005: Michael J Borowitz; D Jeanette Pullen; Naomi J Winick; Paul L Martin; W Paul Bowman; Bruce M Camitta
Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.
Cytometry. Part B, Clinical cytometry 2005;68(1):18-24.
2005: Victor Whitehead; Jonathan J Shuster; MJ Vuchich; Donald H Mahoney; Stephen J Lauer; C Payment; P A Koch; Linda D Cooley; AT Look; D Jeanette Pullen; Bruce M Camitta
Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Leukemia 2005;19(4):533-6.
2003: Michael J Borowitz; D Jeanette Pullen; Jonathan J Shuster; David S Viswanatha; K Montgomery; Cheryl L Willman; Bruce M Camitta
Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study.
Leukemia 2003;17(8):1566-72.
2001: Victor Whitehead; C Payment; Linda D Cooley; Stephen J Lauer; Donald H Mahoney; Jonathan J Shuster; MJ Vuchich; Mark L Bernstein; AT Look; D Jeanette Pullen; Bruce M Camitta
The association of the TEL-AML1 chromosomal translocation with the accumulation of methotrexate polyglutamates in lymphoblasts and with ploidy in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Leukemia 2001;15(7):1081-8.
2000: Nancy R Schneider; Andrew J Carroll; Jonathan J Shuster; D Jeanette Pullen; Michael P Link; Michael J Borowitz; Bruce M Camitta; J A Katz; Michael D Amylon
New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases.
Blood 2000;96(7):2543-9.
2000: Zahid Kaleem; Jonathan J Shuster; Andrew J Carroll; Michael J Borowitz; D Jeanette Pullen; Bruce M Camitta; MM Zutter; Michael S Watson
Acute lymphoblastic leukemia with an unusual t(8;14)(q11.2;q32): a Pediatric Oncology Group Study.
Leukemia 2000;14(2):238-40.
2000: Bradley Pollock; M R DeBaun; Bruce M Camitta; Jonathan J Shuster; Yaddanapudi Ravindranath; D Jeanette Pullen; Vita J Land; Donald H Mahoney; Stephen J Lauer; Sharon B Murphy
Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):813-23.
1999: Jeffrey E Rubnitz; Bruce M Camitta; Hazem H Mahmoud; Susana C Raimondi; Andrew J Carroll; Michael J Borowitz; Jonathan J Shuster; Michael P Link; D Jeanette Pullen; James R Downing; Frederick G. Behm; Ching-Hon Pui
Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):191-6.
1999: Fariba Navid; A D Mosijczuk; D R Head; Michael J Borowitz; Andrew J Carroll; J M Brandt; Michael P Link; M K Rozans; G A Thomas; Molly Schwenn; D J Shields; Teresa J Vietti; D Jeanette Pullen
Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience.
Leukemia 1999;13(1):135-41.
1998: Victor Whitehead; MJ Vuchich; Linda D Cooley; Stephen J Lauer; Donald H Mahoney; Jonathan J Shuster; C Payment; P A Koch; J J Akabutu; T Bowen; Barton A. Kamen; Yaddanapudi Ravindranath; A Emami; AT Look; G P Beardsley; D Jeanette Pullen; Bruce M Camitta
Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
Leukemia & lymphoma 1998;31(5-6):507-19.
1998: Michael J Borowitz; Jeffrey E Rubnitz; M Nash; D Jeanette Pullen; Bruce M Camitta
Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study.
Leukemia 1998;12(11):1764-70.
1998: Michael B Harris; Jonathan J Shuster; D Jeanette Pullen; Michael J Borowitz; Andrew J Carroll; Frederick G. Behm; Vita J Land
Consolidation therapy with antimetabolite-based therapy in standard-risk acute lymphocytic leukemia of childhood: a Pediatric Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2840-7.
1998: Stephen P Hunger; M Z Fall; Bruce M Camitta; Andrew J Carroll; Michael P Link; Stephen J Lauer; Donald H Mahoney; D Jeanette Pullen; Jonathan J Shuster; C Philip Steuber; ML Cleary
E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study.
Blood 1998;91(3):1021-8.
1998: Victor Whitehead; MJ Vuchich; Linda D Cooley; Stephen J Lauer; Donald H Mahoney; Jonathan J Shuster; C Payment; Mark L Bernstein; J J Akabutu; T Bowen; Barton A. Kamen; Michael S Watson; AT Look; D Jeanette Pullen; Bruce M Camitta
Translocations involving chromosome 12p11-13, methotrexate metabolism, and outcome in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(1):183-8.
1997: KW Maloney; Jeffrey E Rubnitz; ML Cleary; L S Frankel; N Hakami; Michael P Link; D Jeanette Pullen; Stephen P Hunger
Lack of ETV6 (TEL) gene rearrangements or p16INK4A/p15INK4B homozygous gene deletions in infant acute lymphoblastic leukemia.
Leukemia 1997;11(7):979-83.
1997: Michael J Borowitz; J Shuster; Andrew J Carroll; M Nash; AT Look; Bruce M Camitta; D Mahoney; Stephen J Lauer; D Jeanette Pullen
Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study.
Blood 1997;89(11):3960-6.
1997: Jeffrey E Rubnitz; Jonathan J Shuster; Vita J Land; Michael P Link; D Jeanette Pullen; Bruce M Camitta; Ching-Hon Pui; James R Downing; Frederick G. Behm
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study.
Blood 1997;89(4):1143-6.
1997: L S Frankel; J Ochs; Jonathan J Shuster; R Dubowy; W Paul Bowman; M Hockenberry-Eaton; Michael J Borowitz; Andrew J Carroll; C Philip Steuber; D Jeanette Pullen
Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493).
Journal of pediatric hematology/oncology 1997;19(1):35-42.
1996: M L Graham; Jonathan J Shuster; Barton A. Kamen; Vita J Land; Michael J Borowitz; Bruce M Camitta; D L Cheo; M P Harrison; B G Leventhal; D P Pinkel; D Jeanette Pullen; P Steuber; Victor Whitehead
Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(2):331-7.
1994: Vita J Land; J J Shuster; W M Crist; Yaddanapudi Ravindranath; Michael B Harris; Robert A Krance; D Pinkel; D Jeanette Pullen
Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(9):1939-45.
1994: Jeffrey E Rubnitz; Michael P Link; J J Shuster; Andrew J Carroll; N Hakami; L S Frankel; D Jeanette Pullen; Michael L Cleary
Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Blood 1994;84(2):570-3.
1994: Mark J Pettenati; N Rao; Marcia M Wofford; J J Shuster; D Jeanette Pullen; M P Ling; C Philip Steuber; A J Carroll
Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A Pediatric Oncology Group (POG) Study (8600/8493).
Cancer genetics and cytogenetics 1994;75(1):6-10.
1993: MS Watson; A J Carroll; Jonathan J Shuster; C Philip Steuber; Michael J Borowitz; Frederick G. Behm; D Jeanette Pullen; Vita J Land
Trisomy 21 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study (8602).
Blood 1993;82(10):3098-102.
1993: Michael J Borowitz; Stephen P Hunger; Andrew J Carroll; Jonathan J Shuster; D Jeanette Pullen; C Philip Steuber; Michael L Cleary
Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study.
Blood 1993;82(4):1086-91.
1993: Jonathan J Shuster; A J Carroll; Thomas Look; Ching-Hon Pui; Vita J Land; J Jackson; D Jeanette Pullen; C Philip Steuber; William M Crist
Management of cytogenetic data in multi-center leukemia trials.
Computer methods and programs in biomedicine 1993;40(4):269-77.
1993: Ching-Hon Pui; Susana C Raimondi; Michael J Borowitz; Vita J Land; Frederick G. Behm; D Jeanette Pullen; M L Hancock; J J Shuster; C Philip Steuber; W M Crist
Immunophenotypes and karyotypes of leukemic cells in children with Down syndrome and acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1361-7.
1993: Michael J Borowitz; Andrew J Carroll; Jonathan J Shuster; A Thomas Look; Frederick G. Behm; D Jeanette Pullen; Vita J Land; P Steuber; W M Crist
Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology Group.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():257-67.
1992: Hazem H Mahmoud; Andrew J Carroll; Frederick G. Behm; Susana C Raimondi; J Schuster; Michael J Borowitz; Vita J Land; D Jeanette Pullen; Teresa J Vietti; William M Crist
The non-random dic(9;12) translocation in acute lymphoblastic leukemia is associated with B-progenitor phenotype and an excellent prognosis.
Leukemia 1992;6(7):703-7.
1992: J M Falletta; Jonathan J Shuster; W M Crist; D Jeanette Pullen; Michael J Borowitz; Moody D Wharam; R Patterson; E Foreman; T J Vietti
Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
Leukemia 1992;6(6):541-6.
1992: M L Graham; Jonathan J Shuster; Barton A. Kamen; D L Cheo; M P Harrison; B G Leventhal; D Jeanette Pullen; Victor Whitehead
Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: a Pediatric Oncology Group pilot study.
Cancer chemotherapy and pharmacology 1992;31(3):217-22.
1991: L Cerezo; Jonathan J Shuster; D Jeanette Pullen; B Brock; Michael J Borowitz; J M Falletta; William M Crist; D R Head
Laboratory correlates and prognostic significance of granular acute lymphoblastic leukemia in children. A Pediatric Oncology Group study.
American journal of clinical pathology 1991;95(4):526-31.
1991: Ching-Hon Pui; L S Frankel; A J Carroll; Susana C Raimondi; J J Shuster; D R Head; W M Crist; Vita J Land; D Jeanette Pullen; C Philip Steuber
Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases.
Blood 1991;77(3):440-7.
1990: A J Carroll; W M Crist; M P Link; Michael D Amylon; D Jeanette Pullen; A H Ragab; G R Buchanan; R S Wimmer; T J Vietti
The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Blood 1990;76(6):1220-4.
1990: Michael J Borowitz; Jonathan J Shuster; Curt I Civin; Andrew J Carroll; A Thomas Look; Frederick G. Behm; Vita J Land; D Jeanette Pullen; W M Crist
Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(8):1389-98.
1990: William M Crist; A J Carroll; Jonathan J Shuster; Frederick G. Behm; M Whitehead; Teresa J Vietti; AT Look; D Mahoney; A Ragab; D Jeanette Pullen
Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study.
Blood 1990;76(1):117-22.
1990: Ching-Hon Pui; Andrew J Carroll; Susana C Raimondi; Vita J Land; William M Crist; Jonathan J Shuster; D L Williams; D Jeanette Pullen; Michael J Borowitz; Frederick G. Behm
Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid less than 45 line.
Blood 1990;75(5):1170-7.
1990: M P Sullivan; D Jeanette Pullen; William M Crist; M Brecher; I Ramirez; H Sabio; Michael J Borowitz; D R Head; L Cerezo; Jonathan J Shuster
Clinical and biological heterogeneity of childhood B cell acute lymphocytic leukemia: implications for clinical trials.
Leukemia 1990;4(1):6-11.
1990: Jonathan J Shuster; J M Falletta; D Jeanette Pullen; William M Crist; G B Humphrey; Barry Dowell; Moody D Wharam; Michael J Borowitz
Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Blood 1990;75(1):166-73.
1988: William M Crist; Jonathan J Shuster; J Falletta; D Jeanette Pullen; CW Berard; Teresa J Vietti; C S Alvarado; M A Roper; E Prasthofer; C E Grossi
Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group Study.
Blood 1988;72(6):1891-7.
1988: R Nuss; G Kitchingman; A Cross; Theodore F Zipf; G R Antoun; Irwin D Bernstein; Frederick G. Behm; D Jeanette Pullen; William M Crist; J Mirro
T cell receptor gene rearrangements in B-precursor acute lymphoblastic leukemia correlate with age and the stage of B cell differentiation.
Leukemia 1988;2(11):722-7.
1987: Andrew J Carroll; Susana C Raimondi; D L Williams; Frederick G. Behm; Michael J Borowitz; R P Castleberry; Michael B Harris; R B Patterson; D Jeanette Pullen; William M Crist
tdic(9;12): a nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
Blood 1987;70(6):1962-5.
1987: Barry Dowell; Michael J Borowitz; J M Boyett; D Jeanette Pullen; William M Crist; F F Quddus; E C Russell; J M Falletta; R S Metzgar
Immunologic and clinicopathologic features of common acute lymphoblastic leukemia antigen-positive childhood T-cell leukemia. A Pediatric Oncology Group Study.
Cancer 1987;59(12):2020-6.
1987: F Morabito; E F Prasthofer; D Jeanette Pullen; D Mahoney; J R Downing; William M Crist; C E Grossi
Analysis of surface antigen profile, TdT expression, and T cell receptor gene rearrangement for maturational staging of leukemic T cells: a pediatric oncology group study.
Leukemia 1987;1(6):514-7.
1986: D R Head; Michael J Borowitz; L Cerezo; C M Craven; B L Brock; J M Boyett; D Jeanette Pullen; William M Crist; J Falletta; G B Humphrey
Acid phosphatase positivity in childhood acute lymphocytic leukemia.
American journal of clinical pathology 1986;86(5):650-3.
1986: Michael J Borowitz; Barry Dowell; J M Boyett; D Jeanette Pullen; William M Crist; F M Quddus; J M Falletta; R S Metzgar
Clinicopathologic aspects of E rosette negative T cell acute lymphocytic leukemia: a Pediatric Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(2):170-7.
1985: F F Quddus; B G Leventhal; J M Boyett; D Jeanette Pullen; William M Crist; Michael J Borowitz
Glucocorticoid receptors in immunological subtypes of childhood acute lymphocytic leukemia cells: a Pediatric Oncology Group Study.
Cancer research 1985;45(12 Pt 1):6482-6.
1985: G B Humphrey; R Blackstock; J M Falletta; R S Metzgar; E R Richie; D Jeanette Pullen; J M Boyett; Jonathan J Shuster; M A Roper; E C Russell
An analysis of the presence of Fc receptors on bone marrow lymphoblasts in acute lymphoblastic leukemia. A Pediatric Oncology Group study.
Cancer 1985;56(8):1995-2000.
1985: Michael J Borowitz; Barry Dowell; J M Boyett; J M Falletta; D Jeanette Pullen; William M Crist; G B Humphrey; R S Metzgar
Monoclonal antibody definition of T cell acute leukemia: a Pediatric Oncology Group study.
Blood 1985;65(4):785-8.
1984: D Jeanette Pullen; J M Boyett; William M Crist; J M Falletta; M Roper; Barry Dowell; J Van Eys; J F Jackson; G B Humphrey; R S Metzgar
Pediatric oncology group utilization of immunologic markers in the designation of acute lymphocytic leukemia subgroups: influence on treatment response.
Annals of the New York Academy of Sciences 1984;428():26-48.
1982: D Jeanette Pullen; M P Sullivan; J M Falletta; J M Boyett; G B Humphrey; K A Starling; Vita J Land; P G Dyment; T Vats; M H Duncan
Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: results and prognostic factors (a Pediatric Oncology Group Study).
Blood 1982;60(5):1159-68.
1981: D Jeanette Pullen; J M Falletta; William M Crist; L B Vogler; Barry Dowell; G B Humphrey; R Blackstock; J V Eys; Max D Cooper; R S Metzgar; E F Meydrech
Southwest Oncology Group experience with immunological phenotyping in acute lymphocytic leukemia of childhood.
Cancer research 1981;41(11 Pt 2):4802-9.
1981: L B Vogler; William M Crist; A M Sarrif; D Jeanette Pullen; Alfred A Bartolucci; J M Falletta; Barry Dowell; G B Humphrey; R Blackstock; J van Eys; R S Metzgar; Max D Cooper
An analysis of clinical and laboratory features of acute lymphocytic leukemias with emphasis on 35 children with pre-B leukemia.
Blood 1981;58(1):135-40.